The KCNQ1 voltage gated K+ channel is expressed in many different tissues and plays widely different roles in these different tissues. Mutations and polymorphisms in KCNQ1 have been implicated in multiple diseases, including cardiac arrhythmias, inherited deafness, and susceptibility to type 2 diabetes. In the heart, KCNQ1 is co-expressed with the beta subunit KCNE1 to form the slowly activating, voltage gated IKs channels that contribute critically to the repolarization of the cardiac action potential at the cellular level and the QT interval of the electrocardiogram. In other cell types, such as epithelia and kidney cells, KCNQ1 is co-expressed with the beta subunits KCNE2 or KCNE3 to form a voltage independent K+ channel that is important for K+ and Cl- secretion. The critical role of KCNQ1 has been revealed by inherited mutations which have been associated with such diverse cardiac rhythm disturbances as the Long QT syndrome, the Short QT Syndrome, and atrial fibrillation. In many cases, co-assembly with the KCNE1 ? subunit dictates pathological function. How different beta subunits and mutations alter the function of KCNQ1 channels is not completely understood. We will here simultaneously measure the movement of the voltage sensor and the activation gate in KCNQ1 channels. This will allow us to determine whether a specific beta subunit or mutation mainly affects the voltage sensor or the gate. We will also test the effects of different modulators, both activators and inhibitors, of KCNQ1 on the voltage sensor movement and the activation gate, in order to understand how these molecules affect KCNQ1 activity and whether these molecules can restore the function of mutant KCNQ1 channels. The completion of these aims will generate a better understanding of how KCNE beta subunits modulate KCNQ1 channel functions, how small molecule modulators affect KCNQ1 channels, and how the defects of disease- causing KCNQ1 mutations can be overcome in a mutation- and small molecule dependent manner. This would be a first step in generating mutation specific treatments of diseases, such as cardiac arrhythmias, caused by mutations in KCNQ1.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Nie, Zhongzhen
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Miami School of Medicine
Schools of Medicine
Coral Gables
United States
Zip Code
Lorberbaum, Tal; Sampson, Kevin J; Woosley, Raymond L et al. (2016) An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval. Drug Saf 39:433-41
Chen, Lei; Sampson, Kevin J; Kass, Robert S (2016) Cardiac Delayed Rectifier Potassium Channels in Health and Disease. Card Electrophysiol Clin 8:307-22
Lorberbaum, Tal; Sampson, Kevin J; Chang, Jeremy B et al. (2016) Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation. J Am Coll Cardiol 68:1756-1764
Bohnen, Michael S; Iyer, Vivek; Sampson, Kevin J et al. (2015) Novel mechanism of transient outward potassium channel current regulation in the heart: implications for cardiac electrophysiology in health and disease. Circ Res 116:1633-5
Liin, Sara I; Barro-Soria, Rene; Larsson, H Peter (2015) The KCNQ1 channel - remarkable flexibility in gating allows for functional versatility. J Physiol 593:2605-15
Barro-Soria, Rene; Perez, Marta E; Larsson, H Peter (2015) KCNE3 acts by promoting voltage sensor activation in KCNQ1. Proc Natl Acad Sci U S A 112:E7286-92
Liin, Sara I; Silverå Ejneby, Malin; Barro-Soria, Rene et al. (2015) Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel. Proc Natl Acad Sci U S A 112:5714-9
Barro-Soria, Rene; Rebolledo, Santiago; Liin, Sara I et al. (2014) KCNE1 divides the voltage sensor movement in KCNQ1/KCNE1 channels into two steps. Nat Commun 5:3750
Zhou, Yun; Wang, Xiaoyu; Tzingounis, Anastasios V et al. (2014) EAAT2 (GLT-1; slc1a2) glutamate transporters reconstituted in liposomes argues against heteroexchange being substantially faster than net uptake. J Neurosci 34:13472-85